- Report
- April 2025
- 307 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- September 2025
- 150 Pages
Middle East
From €4507EUR$4,950USD£3,866GBP
- Report
- May 2025
- 170 Pages
Global
From €5417EUR$5,950USD£4,647GBP
- Report
- September 2024
- 100 Pages
Global
From €5417EUR$5,950USD£4,647GBP
- Report
- May 2024
- 130 Pages
United States
From €5417EUR$5,950USD£4,647GBP
- Report
- December 2023
- 120 Pages
Canada
From €5417EUR$5,950USD£4,647GBP
- Report
- December 2023
- 80 Pages
United States
From €5417EUR$5,950USD£4,647GBP
- Report
- September 2025
- 100 Pages
Global
From €4461EUR$4,900USD£3,827GBP
- Report
- February 2025
Global
From €4461EUR$4,900USD£3,827GBP
- Report
- March 2025
- 201 Pages
Global
From €2276EUR$2,500USD£1,953GBP
- Report
- August 2024
- 130 Pages
North America
From €3642EUR$4,000USD£3,124GBP
- Report
- May 2024
- 85 Pages
Spain
From €3187EUR$3,500USD£2,734GBP
- Report
- November 2023
- 71 Pages
France
From €3187EUR$3,500USD£2,734GBP
- Report
- August 2025
- 198 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- August 2025
- 190 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- August 2025
- 199 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- August 2025
- 194 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- August 2025
- 190 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- August 2025
- 189 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- May 2024
- 200 Pages
Global
From €3779EUR$4,150USD£3,241GBP

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect.
The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals.
Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more